International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators

Depression is disabling and highly prevalent. Intravenous (IV) ketamine displays rapid-onset antidepressant properties, but little is known regarding which patients are most likely to benefit, limiting personalized prescriptions. We identified randomized controlled trials of IV ketamine that recruit...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, Rebecca B., Kissel, Nicholas, Baumeister, Andrew, Rohac, Rebecca, Woody, Mary L., Ballard, Elizabeth D., Zarate, Carlos A., Deakin, William, Abdallah, Chadi G., Feder, Adriana, Charney, Dennis S., Grunebaum, Michael F., Mann, J. John, Mathew, Sanjay J., Gallagher, Bronagh, McLoughlin, Declan M., Murrough, James W., Muthukumaraswamy, Suresh, McMillan, Rebecca, Sumner, Rachael, Papakostas, George, Fava, Maurizio, Hock, Rebecca, Phillips, Jennifer L., Blier, Pierre, Shiroma, Paulo, Šóš, Peter, Su, Tung-Ping, Chen, Mu-Hong, Tiger, Mikael, Lundberg, Johan, Wilkinson, Samuel T., Wallace, Meredith L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763119/
https://www.ncbi.nlm.nih.gov/pubmed/36071111
http://dx.doi.org/10.1038/s41380-022-01757-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763119/
https://www.ncbi.nlm.nih.gov/pubmed/36071111
http://dx.doi.org/10.1038/s41380-022-01757-7

Ejemplares similares